Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
Ferring

March 18, 2009
Paul Korner, M.D., M.B.A. has been named Senior vice president of the Ferring International PharmaScience Center U.S. . . .  Read More »
Cedarburg Acquires InB: Hauser

March 18, 2009
Cedarburg Pharmaceuticals has acquired InB: Hauser Pharmaceutical Services. The acquisition is intended to strengthen Cedarburg’s position in the rapidly growing CDMO market . . .  Read More »
Sanofi-aventis U.S.

March 17, 2009
Paul Chew, M.D., has been appointed to Chief Science Officer/Chief Medical Officer, for sanofi-aventis, U.S., effective April 1. He was previously President, R&D, sanofi-aventis, U.S. In these roles, Dr. Chew will establish a unified medical v…  Read More »
Roche To Acquire Innovatis

March 16, 2009
Roche has signed an agreement to acquire Innovatis, a German-based provider of automated cell analysis solutions, for $19.4 million. Innovatis will become a fully-integrated part of Roche Applied Science, the company’s diagnostic division.  Read More »
ICON, MedAvante Enter Alliance

March 16, 2009
ICON and MedAvante, Inc., a provider of centralized psychiatric patient evaluation, have signed an alliance agreement combining ICON's global reach and expertise in clinical trial management with MedAvante's platform to centralize and calibrate the assess  Read More »
Spectrum Pharmaceuticals Acquires Zevalin

March 16, 2009
Spectrum Pharmaceuticals has completed the transaction acquiring control of RIT Oncology, LLC, to commercialize Zevalin ([90Y]-ibritumomab tiuxetan) in the U.S.  Read More »
Pfizer Stops Pancreatic Trial after Strong Results

March 13, 2009
Pfizer's Phase III trial of Sutent has been stopped early after the drug showed significant benefit in patients with advanced pancreatic islet cell tumors, or pancreatic neuroendocrine tumors.  Read More »
Biogen Idec

March 13, 2009
Cecil B. Pickett, Ph.D. will retire from his position as president, R&D of Biogen Idec. The company has initiated a search for a successor, and will consider both internal and external candidates.   Read More »
Covance Acquires Swiss Site

March 13, 2009
Covance is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.  Read More »
Roche, Genentech Ink Merger

March 12, 2009
Roche and Genentech signed a merger agreement under which Roche will acquire outstanding Genentech shares for approximately $46.8 billion in cash.   Read More »
Gilead To Acquire CV Therapeutics

March 12, 2009
Gilead Sciences has entered into a definitive agreement to acquire CV Therapeutics for approximately $1.4 billion in cash through a tender offer and second-step merger.   Read More »
DSM Obtains Drug Delivery Tech

March 12, 2009
DSM Biomedical has obtained an exclusive worldwide license to a drug and biologics delivery system developed by MediVas LLC.   Read More »
JLL Bids To Take Patheon Private

March 11, 2009
JLL Patheon Holdings, LLC, an affiliate of JLL Partners, has offered $2.00 in cash per Restricted Voting Share for all outstanding shares of Patheon that it does not already own.   Read More »
BASi

March 11, 2009
BASi has expanded its business development team in the U.S. and Europe. Jack Polidoro, Ph.D., will focus on the company's Evansville, IN operation and two additional business development representatives (unnamed) will work out of BASi’s facility in the UK  Read More »
GSK, Prasco Enter Generic Flonase Pact

March 11, 2009
Prasco Laboratories has entered into a marketing and distribution agreement with GlaxoSmithKline for generic Flonase Nasal Spray.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: